Am J Transplant, Volume 20, Suppl 3 Archives - Page 11 of 223 - ATC Abstracts

2020 American Transplant Congress
Waitlist Times, Hospital Length of Stay, and Immediate Post-Operative Outcomes of HCV Positive Donors in HCV Negative Liver and Kidney Transplant Recipients
H. Elbeshbeshy¹, J. M. Ray¹, A. Befeler¹, R. Desai¹, K. Qureshi¹, C. Varma²
¹Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, MO, ²Surgery, Saint Louis University School of Medicine, St. Louis, MO
*Purpose:Introduction The advent of direct-acting antivirals (DAAs) has significantly changed liver and kidney transplantation for patients with chronic hepatitis C (HCV) infection. Successful and relatively…
2020 American Transplant Congress
Cost Utilization and the Use of Pulmonary Functions Tests in Preoperative Liver Transplant
M. LaGoy¹, A. Ermekbaeva², J. Buggs³, S. Nyce⁴, D. Patino⁴, E. Rogers³, A. Kumar¹, N. Kemmer⁵
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²Honors College, University of South Florida, Tampa, FL, ³Transplant Surgery, Tampa General Hospital, Tampa, FL, ⁴University of Tampa, Tampa, FL, ⁵Transplant Hepatology, Tampa General Hospital, Tampa, FL
*Purpose: The American Society of Anesthesia recommends abdominal transplant patients receive pre-operative pulmonary function tests (PFTs) which cost nearly $2,500. Up to 88 percent of…
2020 American Transplant Congress
PHS High Risk: Is this Classification Still Needed?
L. G. Smith
Vanderbilt Transplant Center, Nashville, TN
*Purpose: The continued shortage of organs for the over 100,000 candidates on the waitlist has led transplant centers to consider organs that have historically higher…
2020 American Transplant Congress
Inactive Status Change is an Independent Predictor of Waitlist Mortality and Disproportionately Impacts Patients in Donor Service Areas with a Higher Median MELD at Transplant
R. Batra¹, S. Noreen², D. Stewart³, D. Haakinson¹, G. Gan³, Y. Deng³, S. Kulkarni¹
¹Surgery, Yale University School of Medicine, New Haven, CT, ²UNOS, Richmond, VA, ³Yale University, New Haven, CT
*Purpose: Liver waitlist mortality is calculated by including both active and inactive patients. As inactive patients are unable to receive organ offers, models that adjust…
2020 American Transplant Congress
Domestic U.S. Transplant Tourism: Analysis of U.S. Citizens Who Travel to Another State for Transplant
R. S. Mangus, M. F. Mount
Indiana University, Indianapolis, IN
*Purpose: Transplant tourism is a phenomenon where patients travel away from their home to receive organ transplantation where organs are more readily available. This flow…
2020 American Transplant Congress
Investigating the 6-Month Effects of the UNOS Allocation System Changes on the Post Transplant Outcomes in Patients with Hypertrophic Cardiomyopathy
P. Banankhah¹, C. Lum², A. Salimbangon³, G. Liu¹, A. Wolfson⁴, E. DePasquale¹, R. Chand⁵, P. Genyk¹, P. Kingsford¹, J. Li¹, D. Vucicevic⁶, A. Vaidya¹, K. Pandya¹, J. Rahman¹, M. Fong¹, L. Grazette¹, J. Nattiv¹, S. Hashmi¹, S. Nuno¹, J. Pizula¹, A. Lee¹, K. Yang¹, S. Shah¹
¹Cardiology, University of Southern California, Los Angeles, CA, ²The Queen's Medical Center, Honolulu, HI, ³Cardiology, UCLA Medical Center, Los Angeles, CA, ⁴University of Arizona Sarver Heart Center, Tucson, CA, ⁵Cardiology, Harbor-UCLA Medical Center, Los Angeles, CA, ⁶Cardiology, Newark Beth-Israel Medical Center, Newark, NJ
*Purpose: Hypertrophic cardiomyopathy (HCM) has a broad spectrum of presentations. However, the prognosis is poor in patients presenting with significant chamber remodeling, and they often…
2020 American Transplant Congress
Association of Discharge Immunosuppressive Regimen with Treated Acute Rejection and Bronchiolitis Obliterans Syndrome in Adult Lung Transplantation: An Analysis of Organ Procurement and Transplantation Network Data
W. S. Cherikh¹, B. J. Plucinski¹, S. Palmer², W. E. Fitzsimmons³
¹United Network for Organ Sharing, Richmond, VA, ²Duke University Hospital, Durham, NC, ³Fitzsimmons LLC, Vernon Hills, IL
*Purpose: The optimal immunosuppressive (IS) regimen after lung (LU) transplant is unknown. We conducted the current analysis to compare the effect of four different discharge…
2020 American Transplant Congress
Clinical Evaluation of Lung Transplantation for End-Stage Idiopathic Pulmonary Fibrosis Patients with Lung Cancer
J. Zhang, D. Liu, J. Chen
Lung Transplant Center, Wuxi People's Hospital, Wuxi, China
*Purpose: The treatment of patients with end-stage idiopathic pulmonary fibrosis (IPF) and lung cancer (LC) is a difficult task, and it remains questionable whether LC…
2020 American Transplant Congress
Lower Extremity Vascular Complications after Simultaneous Pancreas Kidney Transplant
H. J. Braun, D. Amara, T. Sorrentino, J. L. Ramirez, J. Lin, A. Mello, P. G. Stock, J. S. Hiramoto
University of California, San Francisco, San Francisco, CA
*Purpose: Type 1 diabetes mellitus (DM) is the leading indication for simultaneous pancreas kidney transplantation (SPK). Prior work has demonstrated a 2% incidence of lower…
2020 American Transplant Congress
Urine Donor Derived Cell Free DNA Aids in the Diagnosis of BK Polyomavirus Nephropathy in Kidney Transplant Recipients with BK Viruria
G. Huang¹, X. Chen¹, W. Chen¹, P. Chen¹, T. Jiang², C. Wang¹, L. Chen¹
¹The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²AlloDx Biotech Co., Ltd, Suzhou, China
*Purpose: BK polyomavirus nephropathy (BKVN) are important cause of dysfunction and failure of renal transplants, which is similar to T cell mediated rejection (TCMR) in…